Peritonitis News and Research

RSS
Peritonitis is an inflammation of the peritoneum, the serous membrane which lines part of the abdominal cavity and viscera. Peritonitis may be localized or generalized, and may result from infection (often due to rupture of a hollow organ as may occur in abdominal trauma or appendicitis) or from a non-infectious process.
FDA designates two of Cubist’s Phase 3 antibiotic candidates

FDA designates two of Cubist’s Phase 3 antibiotic candidates

Cholangiography use endorsed in cholecystectomy

Cholangiography use endorsed in cholecystectomy

Novel serum assay measures calcification risk

Novel serum assay measures calcification risk

Peritoneal dialysis patients who live remotely face high peritonitis risk

Peritoneal dialysis patients who live remotely face high peritonitis risk

Five abstracts evaluating Abbott's LCIG presented at Parkinson's disease congress

Five abstracts evaluating Abbott's LCIG presented at Parkinson's disease congress

Peritonitis commonly arises in the weeks before many dialysis patients die

Peritonitis commonly arises in the weeks before many dialysis patients die

Wake Forest Baptist researchers create emergency general surgery registry

Wake Forest Baptist researchers create emergency general surgery registry

Inhibition of necroptosis protects mice from lethal SIRS

Inhibition of necroptosis protects mice from lethal SIRS

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Positive results from Cubist CXA-201 and CB-183,315 Phase 2 studies for complicated intra-abdominal infections

Positive results from Cubist CXA-201 and CB-183,315 Phase 2 studies for complicated intra-abdominal infections

Abbott reports positive interim results from LCIG Phase III open-label study for advanced Parkinson's disease

Abbott reports positive interim results from LCIG Phase III open-label study for advanced Parkinson's disease

FDA approves APP Pharmaceuticals' Piperacillin and Tazobactam for Injection

FDA approves APP Pharmaceuticals' Piperacillin and Tazobactam for Injection

ViroPharma commences VP 20621 Phase 2 study for prevention of recurrent Clostridium difficile infection

ViroPharma commences VP 20621 Phase 2 study for prevention of recurrent Clostridium difficile infection

Spotlight on the NDM-1 “superbug” highlights the long-standing but increasingly alarming situation of antibiotic resistance globally

Spotlight on the NDM-1 “superbug” highlights the long-standing but increasingly alarming situation of antibiotic resistance globally

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Entry inhibitors can provide first new hepatitis B & D treatments for many years

Challenges of high-risk surgery

Challenges of high-risk surgery

California jury awards $2.2 million in defective laparoscopic device case

California jury awards $2.2 million in defective laparoscopic device case

ViroPharma presents Phase 1 study data of VP20621 at ICAAC 2010

ViroPharma presents Phase 1 study data of VP20621 at ICAAC 2010

Recommendations available for managing ascites, SBP and hepatorenal syndrome

Recommendations available for managing ascites, SBP and hepatorenal syndrome